Welcome to our dedicated page for Swk Hldgs SEC filings (Ticker: SWKH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SWK Holdings Corporation (SWKH) SEC filings page provides access to the company’s official regulatory documents filed with the U.S. Securities and Exchange Commission. As a life science focused specialty finance company with listed common stock and 9.00% Senior Notes due 2027 (SWKHL) on Nasdaq, SWK uses these filings to report its financial condition, portfolio activity, and material corporate events.
Investors can review Form 8-K filings in which SWK furnishes earnings press releases, investor presentations, and details on significant transactions. Recent 8-Ks include disclosures about quarterly financial results, non-GAAP reconciliations, monetization of royalty portfolios, special dividends, and the Agreement and Plan of Merger with Runway Growth Finance Corp. Other periodic reports, such as annual and quarterly filings, provide segment information for the Finance Receivables and Pharmaceutical Development Services businesses, along with discussions of non-GAAP measures like adjusted net income and non-GAAP tangible finance book value per share.
This page also helps users monitor information related to capital structure and securities, including the company’s common stock and its 9.00% Senior Notes due 2027. Filings may describe terms of these securities, risk factors, and updates on portfolio valuations and credit performance.
Stock Titan enhances access to SWKH filings with AI-powered summaries that explain complex sections in plain language, highlight key changes from prior periods, and surface items such as portfolio gains and losses, nonaccrual assets, and merger-related provisions. Real-time updates from EDGAR mean new SWK filings appear promptly, while Form 4 and other ownership reports can be used to track insider and major holder activity where available. This combination of raw documents and AI-generated insights allows investors, analysts, and researchers to review SWK’s regulatory history and understand how its specialty finance and pharmaceutical development activities are reflected in its official disclosures.
SWK Holdings Corporation held a Special Meeting of stockholders on March 31, 2026 and approved the Agreement and Plan of Merger with Runway Growth Finance Corp. under which SWK will merge into a Runway subsidiary. As of the record date, there were 12,095,906 shares issued and outstanding; 11,256,673 shares (93.06%) were represented, constituting a quorum. The Merger Agreement Proposal was approved with 11,240,819 votes in favor, 8,763 votes against and 7,091 abstentions. Non-binding advisory votes to approve executive and director compensation in connection with the Mergers were also approved (Compensation Proposal: 11,214,361 for; Director Compensation Proposal: 11,140,460 for). The Adjournment Proposal was not voted on because sufficient votes existed to approve the Merger Agreement Proposal.
SWK Holdings Corporation stockholders approved the company’s merger agreement with Runway Growth Finance Corp. At the March 31, 2026 special meeting, 11,256,673 shares were represented, equal to 93.06% of the 12,095,906 shares entitled to vote.
The merger agreement proposal passed with 11,240,819 votes for, 8,763 against and 7,091 abstentions. Stockholders also approved, on a non-binding advisory basis, the compensation that may be paid to SWK’s named executive officers and directors in connection with the mergers. An adjournment proposal was not needed because approval thresholds were met.
SWK Holdings Corporation files its Annual Report outlining a specialty finance strategy focused on healthcare and life sciences. The company’s business now centers on its Finance Receivables segment after selling substantially all assets of its Pharmaceutical Development segment in 2025.
SWK provides royalty-backed and revenue interest financings, mainly in sub-$50 million transactions, and has funded about $876.1 million across 58 parties as of March 7, 2026. As of June 30, 2025, common equity held by non-affiliates was valued at $45,770,456, and 12,095,979 common shares were outstanding as of March 16, 2026.
The report highlights extensive risk factors, including credit losses on royalty and debt investments, heavy regulation of life sciences, dependence on third parties to market royalty-generating products, limited portfolio diversification, cybersecurity and AI-related risks, significant influence from a controlling stockholder group, and potential impacts from announced mergers.
SWK Holdings Corporation is asking shareholders to approve a three-step merger with Runway Growth Finance Corp. (RWAY) at a virtual special meeting on March 31, 2026; the record date for voting is March 2, 2026. The SWK Board unanimously recommends voting FOR the Merger Proposal and related items.
At the Effective Time, each outstanding share of SWK Common Stock (other than cancelled shares) will be converted, at the holder’s election, into either (A) newly issued RWAY shares determined by an Exchange Ratio calculated from SWK and RWAY per-share NAVs determined two business days before closing (the "Determination Date") or (B) cash equal to SWK Per Share NAV, plus a pro rata share of a $9,000,000 guaranteed cash payment from the Adviser. As of the record date there were 12,095,906 shares of SWK Common Stock outstanding and Double Black Diamond Offshore, Ltd. beneficially owned approximately 8,493,088 shares (about 70.21%).
SWK Holdings Corporation entered into a Seventh Amendment to its Credit Agreement with First Horizon Bank and other lenders. Effective February 12, 2026, the amendment revises the financial covenants and reduces the aggregate lending commitments from $10.0 million to $7.5 million.
The amendment relates to the company’s existing facility originally dated June 28, 2023, and is documented in the filed Seventh Amendment to Credit Agreement, which is incorporated by reference as an exhibit.
SWK Holdings outlined terms of its proposed merger with Runway Growth Finance (RWAY), combining cash and stock consideration determined shortly before closing. The cash portion from RWAY will be calculated from SWK’s NAV determined 48 hours prior to close, less deferred tax assets, intangible assets, and SWK transaction expenses, then reduced by a fixed $75.5M book-value stock component. An additional $9.0M cash payment will come from RWAY’s external manager.
SWK shareholders will receive a fixed $75.5M of RWAY shares, subject to a 19.9% cap relative to RWAY’s outstanding common stock. Using RWAY’s NAV per share of $13.55 as of 9/30/25, this equates to roughly 5.572M shares; based on a 20‑day VWAP of $9.85 as of November 6, 2025, the stock component’s market value was about $54.9M. The company targets an expected close in early 2026, notes a change‑of‑control bond offer to call at par, and indicates the transaction is expected to be a taxable event.
Runway Growth Finance discussed Q3 2025 results and its proposed merger to acquire SWK Holdings, a healthcare and life sciences lender. Runway reported total investment income of $36.7 million and net investment income of $15.7 million, completing $128.3 million of funded loans across technology, healthcare and select consumer sectors.
The portfolio had $946 million in fair value, a debt yield of 16.8%, and one non‑accrual loan with a fair value of $2.4 million (0.2% of the portfolio). NAV per share was $13.55; leverage was 0.92x. Liquidity totaled $371.9 million with borrowing capacity of $364.0 million. The board declared a Q4 regular distribution of $0.33 per share; Q3 NII was $0.43 per share with spillover income of $0.53.
The parties announced a NAV‑for‑NAV merger with an estimated purchase price of ~$220 million, including $75.5 million in Runway shares valued at closing NAV and ~$145 million in cash, plus a $9 million cash contribution from the adviser. Runway expects mid‑single digit run‑rate NII accretion in the first full quarter post‑close and to increase healthcare exposure to about 31% from 14%. Closing is anticipated in early 2026.
Runway Growth Finance Corp. announced a proposed merger with SWK Holdings Corporation and outlined expected financial and portfolio impacts. The company anticipates mid single-digit run-rate net investment income (NII) accretion during the first full quarter following closing, with pro forma leverage moving to ~1.1x. Management highlighted potential benefits including enhanced scale, broader funding access, and a lowered risk profile from smaller average loan positions.
Operationally, the portfolio at fair value was $946 million as of September 30, 2025, with a weighted average debt investment yield of 16.83%. For the same period, NAV per share was $13.55 and NII per share was $0.43. The platform reported 98% first lien exposure and a cumulative net loss rate of 0.61% since inception, supported by disciplined underwriting and active monitoring. Management also cited improved trading liquidity and funding flexibility as potential post-combination advantages, subject to completion of the merger and customary conditions.
SWK Holdings reported solid Q3 results as it completes its shift to a single operating segment. For the quarter ended September 30, 2025, revenue was $10.9 million and net income was $8.8 million ($0.72 per diluted share), up from $3.5 million a year ago. Year-to-date net income reached $16.9 million.
The finance book generated interest income of $10.8 million in Q3, aided by a $0.9 million benefit for credit losses and $2.6 million unrealized gains on warrants. Finance receivables, net, were $245.4 million with the allowance for credit losses reduced to $7.7 million from $11.2 million at year-end. Three royalty positions—Flowonix ($6.6 million), Best ($2.3 million) and Ideal ($2.5 million)—were on nonaccrual.
Strategically, the company sold most of its royalty portfolio to Soleus for approximately $34.0 million, recording a $3.7 million revaluation loss, and paid a special cash dividend of $4.00 per share in May. It also sold MOD3 assets to Aptar for about $6.9 million, recognizing a $1.6 million gain, and will report only the Finance Receivables segment after Q3. Cash was $10.2 million, the revolver had no balance, and $32.969 million of 9.00% senior notes due 2027 remained outstanding. Shares outstanding were 12,095,906 as of October 31, 2025.
SWK Holdings Corporation filed a Form 8-K to furnish a press release containing its 2025 quarterly financial results. The press release, dated November 6, 2025 and attached as Exhibit 99.1, provides an update on the company’s performance for a 2025 quarter.
The company states that the press release and related information are being furnished, not filed, so they are not subject to certain liability provisions of the Exchange Act and are not automatically incorporated into other Securities Act or Exchange Act filings unless specifically referenced.